LifeScience Biologics

INOVIQ's SubB2M/CA15-3 Breast Cancer Test Shows Excellent Clinical Data

INOVIQ's SubB2M/CA15-3 breast cancer test detects all-stages of breast cancer with excellent accuracy (87%), sensitivity (81%) and specificity (93%) The...

 June 28, 2023 | News

Innovent and RemeGen Collaborate on Clinical Trial for Combined Therapy of TYVYT® and Novel ADCs in China

Under the agreement, Innovent will provide clinical drug supplies of TYVYT® (sintilimab injection) during the clinical trial collaboration. RemeGen wil...

 June 26, 2023 | News

Brii Biosciences to Sell Equity Interest in Qpex Biopharma and Acquire Global Rights for BRII-693

Company acquires exclusive global rights of the novel lipopeptide BRII-693 for the difficult to treat MDR/XDR gram-negative bacterial infections &nbs...

 June 26, 2023 | News

Cognigenics' Intranasal CRISPR Delivery Overcomes Blood-Brain Barrier; Promising Therapeutic Breakthrough

Cognigenics CEO John L. Mee announces breakthrough results from an animal study published today in PNAS Nexus. The findings point to the pot...

 June 23, 2023 | Analysis

Anthem Biosciences Partners with Veeva to Drive Quality Excellence

 Veeva Systems (NYSE: VEEV)  announced that fast-growing contract development and manufacturing organization (CDMO) Anthem Biosciences&...

 June 22, 2023 | News

Everest Medicines' Partner Calliditas Presents Nefecon Data at ERA-EDTA Congress

The presentations showed data and analyses from the NefIgArd Phase 3 clinical trial evaluating Nefecon in patients with IgA nephropathy (IgAN). The study m...

 June 21, 2023 | News

GenScript Debuts AmMag™ Quatro to Revolutionize Automated Plasmid Maxi-Prep Purification

 GenScript Biotech Corporation, the world's leading provider of life-science research tools and services, has added the AmMag™ Quatro a...

 June 21, 2023 | News

Curocell Announces Positive Updates on Next-Gen Anti-CD19 CAR-T at ICML 2023

  84% ORR (32 of 38 patients) and 71% CR (27 of 38 patients) documented after 2 million cells/kg dose anbal-cel treatment to patients in relap...

 June 20, 2023 | News

Hyundai Bioscience's Xafty, the 'Penicillin' of Antivirals, Revolutionizes Treatment of Respiratory Viral Infections with Single Drug

Dr. Jo White evaluated Xafty's clinical results as "The birth of Penicillin of Antivirals" and "a groundbreaking achievement that suggests a so...

 June 19, 2023 | News

Gilead Sciences Singapore Discusses Access and Affordability of CAR T-Cell Therapy in Singapore and Beyond

Can you elaborate on the current availability and accessibility of CAR T-cell therapies in Singapore? What are the key considerations or barriers that need...

 June 19, 2023 | News

Synthetic Biology Revolution: CABIO Pioneers Biotech's Life-Nourishing Future

The Summit responded positively to the national "14th Five-Year Plan" and invited top experts and scholars in the field of synthetic biology from various s...

 June 14, 2023 | News

upGrad enters Pacific Region to set up the largest Institute of Medical Sciences

UIMS is expected to invite enrolments from the second half of June this year. The announcement comes soon after Indian Prime Minister Narendra Modi&n...

 June 14, 2023 | News

InnoCan Pharma Submits New Patent Applications for Advanced Pain Relief Technology

 InnoCan Pharma Corporation (CSE:INNO) ("Innocan Pharma" or the "Company"), a pharmaceutical technology company leveraging its novel cannabis-bas...

 June 13, 2023 | News

Parse Biosciences Launches CRISPR Detect

Parse Biosciences, a leading provider of accessible and scalable single cell sequencing solutions, announced today the launch of CRISPR Detect, enabling si...

 June 09, 2023 | News


News

Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close